LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
Sanjiv S. Agarwala(Goethe University Frankfurt), Alexander M.M. Eggermont(University Medical Center Utrecht), Loretta M. Itri(National Institutes of Health), Ulrich Keilholz(German Cancer Research Center), Richard Kay, Stefan Suciu(St James's University Hospital), Jane Wu, E Gilles, Cy A. Stein(City Of Hope National Medical Center), Agop Y. Bedikian(The University of Texas MD Anderson Cancer Center)
Cited by 138
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k